From: Downstream consequences of diagnostic error in pediatric anaphylaxis
Overall (n = 211) n(%) | ED Dx anaphylaxis (n = 105) n(%) | ED NOT Dx anaphylaxis (n = 106) n(%) | Odds ratio (95% CI) | P value | |
---|---|---|---|---|---|
Action plan | |||||
Action Plan provided | 59 (28.0%) | 34 (32.4%) | 25 (23.6%) | N/A | 0.12 |
Already had action plan | 5 (2.4%) | 4 (3.8%) | 1 (0.9%) | ||
No mention of action plan | 147 (69.7%) | 67 (63.8%) | 80 (75.5%) | ||
Allergen avoidance advice provided | 45 (21.3%) | 23 (21.9%) | 22 (20.8%) | 1.07 (0.55–2.07) | 0.87 |
Autoinjector prescription | |||||
Autoinjector available on discharge | 124 (58.8%) | 86 (81.9%) | 38 (35.8%) | 4.12 (2.07–8.22) | < 0.001 |
Autoinjector prescribed | 109 (51.7%) | 76 (72.4%) | 33 (31.1%) | N/A | < 0.001 |
Already had autoinjector | 15 (7.1%) | 10 (9.5%) | 5 (4.7%) | ||
No mention of autoinjector in notes | 87 (41.2%) | 19 (18.1%) | 68 (64.2%) | ||
Allergist referral | |||||
Allergist referral made | 54 (25.6%) | 37 (35.2%) | 17 (16.0%) | 2.85 (1.48–5.49) | < 0.01 |
Allergist recommended but no referral | 55 (26.1%) | 26 (24.8%) | 29 (27.4%) | 0.87 (0.47–1.62) | 0.75 |
Known to allergista | 46 (21.8%) | 33 (31.4%) | 13 (12.3%) | 3.28 (1.61–6.68) | < 0.001 |
Mention of allergist in ED notes | 126 (59.8%) | 74 (70.5%) | 52 (49.1%) | 2.48 (1.41–4.37) | < 0.01 |
Observation | |||||
Median length of stay in minutes (IQR) | N/A | 265 (201.5–372) | 181.5 (117–272.25) | N/A | < 0.001 |
In ED > 4 h | 90 (42.7%) | 59 (56.2%) | 31 (29.2%) | 3.10 (1.76–5.48) | < 0.001 |
Median time of observation post epinephrine in minutes(IQR) | 314 (256–629) | 216 (129–490.5) | N/A | N/A | 0.01 |
Observed > 4 h post epinephrine | 28 (90.3%) | 6 (35.3%) | 17.11 (3.63–80.77) | < 0.001 | |
ED disposition | |||||
Discharged home | 57 (27.0%) | 11 (10.5%) | 46 (43.4%) | N/A | < 0.001 |
Short stay | 132 (62.6%) | 83 (79.0%) | 49 (46.2%) | ||
Ward | 20 (9.5%) | 9 (8.6%) | 11 (10.4%) | ||
ICU Transfer | 2 (0.9%) | 2 (1.9%) | 0 (0%) |